Prothya Biosolutions Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
1,100
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
- Investments
-
4
Prothya Biosolutions General Information
Description
Provider of plasma medicines manufacturing services intended to serve the pharmaceutical industry. The company manufactures a broad range of medicines derived from blood plasma that is used for a large number of disorders, thereby offering contract manufacturing and tech transfer services to pharmaceutical companies.
Contact Information
Website
www.prothya.com(Operating Subsidiary)
Corporate Office
- Plesmanlaan 125
- Sanquin building
- 1066 CX Amsterdam
- Netherlands
Corporate Office
- Plesmanlaan 125
- Sanquin building
- 1066 CX Amsterdam
- Netherlands
Prothya Biosolutions Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Prothya Biosolutions Patents
Prothya Biosolutions Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024123182-A1 | Altering rna sequences in non-coding regions for modification of protein expression | Inactive | 09-Dec-2022 | ||
| JP-7631296-B2 | Factor h enhancing antibodies and uses thereof | Active | 17-Jul-2019 | ||
| CA-3147638-A1 | Factor h potentiating antibodies and uses thereof | Pending | 17-Jul-2019 | ||
| EP-3999073-A1 | Factor h potentiating antibodies and uses thereof | Pending | 17-Jul-2019 | ||
| EP-3999073-A4 | Factor h potentiating antibodies and uses thereof | Pending | 17-Jul-2019 | A61K31/7088 |
Prothya Biosolutions Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Prothya Biosolutions Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Prothya Biosolutions Investments (4)
Prothya Biosolutions’s most recent deal was a Buyout/LBO with Hírös Plazma. The deal was made on 01-Jun-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hírös Plazma | 01-Jun-2022 | Buyout/LBO | Laboratory Services (Healthcare) | ||
| Körös Plasma | 01-Jun-2022 | Buyout/LBO | Pharmaceuticals | ||
| Pelikán Plazma | 01-Jun-2022 | Buyout/LBO | Pharmaceuticals | ||
| Vértes Plazma | 01-Jun-2022 | Buyout/LBO | Other Pharmaceuticals and Biotechnology |
Prothya Biosolutions FAQs
-
When was Prothya Biosolutions founded?
Prothya Biosolutions was founded in 2015.
-
Where is Prothya Biosolutions headquartered?
Prothya Biosolutions is headquartered in Amsterdam, Netherlands.
-
What is the size of Prothya Biosolutions?
Prothya Biosolutions has 1,100 total employees.
-
What industry is Prothya Biosolutions in?
Prothya Biosolutions’s primary industry is BPO/Outsource Services.
-
Is Prothya Biosolutions a private or public company?
Prothya Biosolutions is a Private company.
-
What is Prothya Biosolutions’s current revenue?
The current revenue for Prothya Biosolutions is .
-
How much funding has Prothya Biosolutions raised over time?
Prothya Biosolutions has raised $106M.
-
Who are Prothya Biosolutions’s investors?
Biosolutions L.L.C., Epstein Capital, Fortissimo Capital, Mesola Inversiones SL, and OBF investments are 5 of 7 investors who have invested in Prothya Biosolutions.
-
When was Prothya Biosolutions acquired?
Prothya Biosolutions was acquired on 20-Oct-2025.
-
Who acquired Prothya Biosolutions?
Prothya Biosolutions was acquired by Intas Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
